Effect of GnRH agonist and hCG treatment on VEGF, angiopoietin-2, and VE-cadherin: Trying to explain the link to ovarian hyperstimulation syndrome

Fertility and Sterility

Volumn 95, Issue 8, 2011, Pages 2517-2519

  Cerrillo, María ^a,b   Pacheco, Alberto ^a,b   Rodríguez, Sara ^a,b   Gómez, Raúl ^a,b   Delgado, Francisco ^a,b   Pellicer, Antonio ^a,b   Garcia Velasco, Juan A ^a,b,c  

^a UNIVERSIDAD REY JUAN CARLOS   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

^c IVI Madrid   (Spain)

Author keywords

GnRH agonist; hCG; OHSS; VEGF

Indexed keywords

ANGIOPOIETIN 2; ESTRADIOL; MESSENGER RNA; PROGESTERONE; RECOMBINANT CHORIONIC GONADOTROPIN; RECOMBINANT FOLLITROPIN; TRIPTORELIN; VASCULAR ENDOTHELIAL CADHERIN;

ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ESTRADIOL BLOOD LEVEL; GRANULOSA CELL; HUMAN; MAJOR CLINICAL STUDY; OOCYTE; OVARY FOLLICLE FLUID; OVARY HYPERSTIMULATION; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION;

ANGIOPOIETIN-2; ANTIGENS, CD; CADHERINS; CHORIONIC GONADOTROPIN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FERTILITY AGENTS, FEMALE; FOLLICULAR FLUID; GONADOTROPIN-RELEASING HORMONE; GRANULOSA CELLS; HUMANS; OOCYTE DONATION; OVARIAN HYPERSTIMULATION SYNDROME; OVULATION INDUCTION; PREGNANCY; PROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SPAIN; TRIPTORELIN; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 79959743460     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2010.12.054     Document Type: Article

References (24)

1. J. Balasch, F. Fabregues, and V. Arroyo Peripheral arterial vasodilation hypothesis: a new insight into pathogenesis of ovarian hyperstimulation syndrome Hum Reprod 13 1998 2718 2730 (Pubitemid 28482716)
2. N. McClure, D.L. Healy, P.A. Rogers, J. Sullivan, L. Beaton, and R.V. Haning Vascular endothelial growth factor as capillary permeability agent in ovarian hyperstimulation syndrome Lancet 344 1994 235 236 (Pubitemid 24229013)
3. Y. Abramov, V. Barak, B. Nisman, and J.G. Schenker Vascular endothelial growth factor plasma levels correlate to the clinical picture in severe ovarian hyperstimulation syndrome Fertil Steril 68 1997 133 137
4. S.R. Soares, R. Gómez, C. Simón, J.A. Garcia-Velasco, and A. Pellicer Targeting the vascular endothelial growth factor system to prevent ovarian hyperstimulation syndrome Hum Reprod Update 14 2008 321 333 (Pubitemid 351858972)
5. A. Villasante, A. Pacheco, A. Ruiz, A. Pellicer, and J.A. Garcia-Velasco Vascular endothelial cadherin regulates vascular permeability: implications for ovarian hyperstimulation syndrome J Clin Endocrinol Metab 92 2007 314 321 (Pubitemid 46067549)
6. H.M. Fraser Regulation of the ovarian follicular vasculature Reprod Biol Endocrinol 12 2006 4 18
7. A. Lanzone, A.M. Fulghesu, R. Apa, A. Caruso, and S. Mancuso LH surge induction by GnRH agonist at the time of ovulation Gynecol Endocrinol 3 1989 213 224
8. Y. Gonen, H. Balakier, W. Powell, and R.F. Casper Use of gonadotropin-releasing hormone agonist to trigger follicular maturation for in vitro fertilization J Clin Endocrinol Metab 71 1990 918 922
9. G. Griesinger, K. Diedrich, P. Devroey, and E.M. Kolibianakis GnRH Agonist for triggering final oocyte maturation in the GnRH antagonist ovarian hyperstimulation protocol: a systematic review and meta-analysis Hum Reprod Update 12 2006 159 168 (Pubitemid 43239269)
10. S. Kol, and I. Solt GnRH agonist for triggering final oocyte maturation in patients at risk of ovarian hyperstimulation syndrome: still a controversy? J Assist Reprod Genet 25 2008 63 66
11. S.J. Pocock Clinical trials: a practical approach 1984 Wiley Science Series Somerset, UK
12. P. Chomczynski, and N. Sacchi Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction Anal Biochemical 162 1987 156 159 (Pubitemid 17064313)
13. -ΔΔCt method Methods 25 2001 402 408 (Pubitemid 34164012)
14. J. Bellver, E.A. Muñoz, A. Ballesteros, S.R. Soares, E. Bosch, and C. Simón Intravenous albumin does not prevent moderate-severe ovarian hyperstimulation syndrome in high-risk IVF patients: a randomized controlled study Hum Reprod 18 2003 2283 2288 (Pubitemid 37427804)
15. F. Parborell, G. Irusta, A. Rodríguez Celín, and M. Tesone Regulation of ovarian angiogenesis and apoptosis by GnRH-I analogs Mol Reprod Dev 75 2008 623 631 (Pubitemid 351323772)
16. Y. Gonen, H. Balakier, W. Powell, and R.F. Casper Use of gonadotropin-releasing hormone agonist to trigger follicular maturation for in vitro fertilization J Clin Endocrinol Metab 71 1990 918 922
17. D. Bodri, J.J. Guillén, A. Polo, M. Trullenque, C. Esteve, and O. Coll Complications related to ovarian stimulation and oocyte retrieval in 4052 oocyte donor cycles Reprod Biomed Online 17 2008 237 243
18. A. Pellicer, C. Albert, A. Mercader, F. Bonilla-Musoles, J. Remohí, and C. Simon The pathogenesis of ovarian hyperstimulation syndrome: in vivo studies investigating the role of interleukin (IL)-1B, IL-6 and vascular endothelial growth factor (VEGF) Fertil Steril 71 1999 482 489 (Pubitemid 29094125)
19. R. Gómez, C. Simón, J. Remohí, and A. Pellicer Vascular endothelial growth factor receptor-2 activation induces vascular permeability in hyperstimulated rats, and this effect is prevented by receptor blockade Endocrinology 143 2002 4339 4348 (Pubitemid 35239566)
20. R. Gómez, C. Simón, J. Remohí, and A. Pellicer Administration of moderate and high doses of gonadotropins to female rats increases ovarian vascular endothelial growth factor (VEGF) and VEGF receptor 1 expression that is associated to vascular hypermeability Biol Reprod 68 2003 2164 2171 (Pubitemid 36687009)
21. M. Thomas, and H.G. Augustin The role of the angiopoietins in vascular morphogenesis Angiogenesis 12 2009 125 137
22. N.F. Vlahos, and O. Gregoriou Prevention and management of ovarian hyperstimulation syndrome Ann N Y Acad Sci 1092 2006 247 264 (Pubitemid 47092342)
23. J. Balasch, F. Fabregues, and V. Arroyo Peripheral arterial vasodilation hypothesis: a new insight into pathogenesis of ovarian hyperstimulation syndrome Hum Reprod 13 1998 2718 2730 (Pubitemid 28482716)
24. A. Villasante, A. Pacheco, E. Pau, A. Ruiz, A. Pellicer, and J.A. Garcia-Velasco Soluble vascular endothelial-cadherin levels correlate with clinical and biological aspects of severe ovarian hyperstimulation syndrome Hum Reprod 23 2008 662 667 (Pubitemid 351651225)